Laboratory Corp. of America Holdings | Key People and Executives
David P. King
Chairman, President & Chief Executive Officer
Richelle P. Parham
Independent Director
D. Gary Gilliland
Independent Director
Garheng Kong
Independent Director
Peter M. Neupert
Independent Director
Jean-Luc Bélingard
Independent Director
Robert Sanders Williams
Independent Director
Robert E. Mittelstaedt
Lead Independent Director
Kerrii B. Anderson
Independent Director
Adam H. Schechter
Independent Director
David P. King
Chairman, President & Chief Executive Officer
Glenn Andrew Eisenberg
Chief Financial Officer, Treasurer & Executive VP
Steven Anderson
Chief Scientific Officer-Covance & Senior VP
Brian J. Caveney
Chief Medical Officer
Marcia T. Eisenberg
Chief Scientific Officer & Senior Vice President
Lance V. Berberian
Chief Information Officer & Senior Vice President
Bryan Vaughn
Senior Vice President Hospitals & Health Systems
Gary M. Huff
CEO-LabCorp Diagnostics
John D. Ratliff
Chief Executive Officer-Covance Drug Development
F. Samuel Eberts
Secretary, Chief Legal & Compliance Officer
Edward T. Dodson
Chief Accounting Officer & Senior Vice President
Pattie Kushner
Vice President-Corporate Communications
Scott Frommer
Vice President-Investor Relations
Lisa J. Uthgenannt
Chief Human Resources Officer
Richelle P. Parham
Independent Director
D. Gary Gilliland
Independent Director
Garheng Kong
Independent Director
Peter M. Neupert
Independent Director
Jean-Luc Bélingard
Independent Director
Robert Sanders Williams
Independent Director
Robert E. Mittelstaedt
Lead Independent Director
Kerrii B. Anderson
Independent Director
Adam H. Schechter
Independent Director
| Address |
358 South Main Street
Burlington North Carolina 27215
United States
|
|
Employees
|
- |
| Website |
http://www.labcorp.com |
| Updated |
07/08/2019 |
| Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. |
